{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:40:40Z","timestamp":1792644040735,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012434","name":"Middle-aged and Young Teachers' Basic Ability Promotion Project of Guangxi","doi-asserted-by":"publisher","award":["2025KY0107"],"award-info":[{"award-number":["2025KY0107"]}],"id":[{"id":"10.13039\/501100012434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U25A20598"],"award-info":[{"award-number":["U25A20598"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22167005"],"award-info":[{"award-number":["22167005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejmech.2026.119365","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:15:48Z","timestamp":1790291748000},"page":"119365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The Pt(IV) complexes of norcantharidin axial-modulated by carboxylic acid ligand: Synthesis, characterization, in vitro\/in vivo anticancer efficacy and hypoxic activity"],"prefix":"10.1016","volume":"320","author":[{"given":"Tong-yan","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-bin","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha-sha","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-chun","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-xue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3087-043X","authenticated-orcid":false,"given":"Yan-cheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6131-7181","authenticated-orcid":false,"given":"Hong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Storr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejmech.2026.119365_bib1","article-title":"Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancer","volume":"5","author":"Galsky","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.ejmech.2026.119365_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100938","article-title":"Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms","volume":"68","author":"Li","year":"2023","journal-title":"Drug Resist. Updates"},{"issue":"8","key":"10.1016\/j.ejmech.2026.119365_bib3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.scib.2017.03.008","article-title":"Platinum drugs: from Pt(II) compounds, Pt(IV) prodrugs, to Pt nanocrystals\/nanoclusters","volume":"62","author":"Hu","year":"2017","journal-title":"Sci Bull (Beijing)"},{"issue":"4","key":"10.1016\/j.ejmech.2026.119365_bib4","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.31635\/ccschem.024.202404412","article-title":"Ultrasound irradiation-induced superoxide anion radical mediates the reduction of tetravalent platinum prodrug for Antitumor therapy","volume":"7","author":"Kong","year":"2025","journal-title":"CCS Chem."},{"issue":"50","key":"10.1016\/j.ejmech.2026.119365_bib5","doi-asserted-by":"crossref","first-page":"20346","DOI":"10.1021\/acs.inorgchem.2c02806","article-title":"A unique chemo-photodynamic antitumor approach to suppress hypoxia via ultrathin graphitic carbon nitride nanosheets supported a Platinum(IV) prodrug","volume":"61","author":"Xu","year":"2022","journal-title":"Inorg. Chem."},{"issue":"18","key":"10.1016\/j.ejmech.2026.119365_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202302156","article-title":"Multitargeted Platinum(IV) anticancer complexes bearing pyridinyl ligands as axial leaving groups","volume":"62","author":"Zhou","year":"2023","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119365_bib7","doi-asserted-by":"crossref","first-page":"9162","DOI":"10.1021\/acs.jmedchem.4c02509","article-title":"Platinum(IV) complexes trigger death receptors and natural killer cells to suppress breast cancer","volume":"68","author":"Cai","year":"2025","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119365_bib8","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1039\/D4DT03162H","article-title":"Autophagy-targeted Pt(IV) agents: a new horizon in antitumor drug development","volume":"54","author":"Li","year":"2025","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2026.119365_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2025.113003","article-title":"The novel platinum(IV) prodrug of cisplatin axially conjugated with cannabidiol induces mitochondrial dysfunction and synergistically enhances anti-tumor effects","volume":"272","author":"Lv","year":"2025","journal-title":"J. Inorg. Biochem."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119365_bib10","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.7150\/thno.29820","article-title":"GSH-sensitive Pt(IV) prodrug-loaded phase-transitional nanoparticles with a hybrid lipid-polymer shell for precise theranostics against ovarian cancer","volume":"9","author":"Huang","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.ejmech.2026.119365_bib11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jcis.2021.05.107","article-title":"A sequentially responsive nanogel via Pt(IV) crosslinking for overcoming GSH-mediated platinum resistance","volume":"601","author":"Xu","year":"2021","journal-title":"J. Colloid Interface Sci."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119365_bib12","doi-asserted-by":"crossref","first-page":"7852","DOI":"10.1021\/acsnano.3c06194","article-title":"A trisulfide bond containing biodegradable polymer delivering Pt(IV) prodrugs to deplete glutathione and donate H(2)S to boost chemotherapy and antitumor immunity","volume":"18","author":"Li","year":"2024","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.ejmech.2026.119365_bib13","doi-asserted-by":"crossref","first-page":"7933","DOI":"10.1021\/acs.jmedchem.2c00472","article-title":"Platinum(IV) prodrugs with cancer stem cell inhibitory effects on lung cancer for overcoming drug resistance","volume":"65","author":"Wang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119365_bib14","first-page":"185","article-title":"Pt(IV) prodrug initiated microparticles from microfluidics for tumor chemo-, photothermal and photodynamic combination therapy","volume":"24","author":"Zhang","year":"2023","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.ejmech.2026.119365_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113730","article-title":"Targeting ROS-AMPK pathway by multiaction Platinum(IV) prodrugs containing hypolipidemic drug bezafibrate","volume":"223","author":"Qiao","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119365_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121856","article-title":"Activating cGAS-STING pathway with ROS-responsive nanoparticles delivering a hybrid prodrug for enhanced chemo-immunotherapy","volume":"290","author":"Cao","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejmech.2026.119365_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122835","article-title":"Novel platinum therapeutics induce rapid cancer cell death through triggering intracellular ROS storm","volume":"314","author":"Liu","year":"2025","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.ejmech.2026.119365_bib18","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1021\/acs.jmedchem.3c02182","article-title":"Novel NF-kappaB inhibitor-conjugated Pt(IV) prodrug to enable cancer therapy through ROS\/ER stress and mitochondrial dysfunction and overcome multidrug resistance","volume":"67","author":"Wang","year":"2024","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119365_bib19","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1186\/s12951-024-02981-9","article-title":"An encounter between metal ions and natural products: natural products-coordinated metal ions for the diagnosis and treatment of tumors","volume":"22","author":"Liu","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119365_bib20","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1039\/B813363H","article-title":"Potential new inorganic antitumour agents from combining the anticancer traditional Chinese medicine (TCM) liriodenine with metal ions, and DNA binding studies","author":"Chen","year":"2009","journal-title":"Dalton Trans."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119365_bib21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jinorgbio.2010.10.007","article-title":"Potential new inorganic antitumour agents from combining the anticancer traditional Chinese medicine (TCM) matrine with Ga(III), Au(III), Sn(IV) ions, and DNA binding studies","volume":"105","author":"Chen","year":"2011","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.ejmech.2026.119365_bib22","doi-asserted-by":"crossref","first-page":"9659","DOI":"10.2147\/IJN.S479212","article-title":"Novel strategies for tumor treatment: harnessing ROS-Inducing active ingredients from traditional Chinese medicine through multifunctional nanoformulations","volume":"19","author":"Zhang","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejmech.2026.119365_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jare.2021.07.010","article-title":"A Tumor-Specific Ferric-Coordinated Epigallocatechin-3-gallate cascade nanoreactor for glioblastoma therapy","volume":"34","author":"Mu","year":"2021","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ejmech.2026.119365_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.111773","article-title":"Ruthenium(II)-curcumin liposome nanoparticles: synthesis, characterization, and their effects against cervical cancer","volume":"204","author":"Lakshmi","year":"2021","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119365_bib25","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1039\/D5MD00917K","article-title":"On the history, synthesis, and medicinal use of cantharidin, LB-100, and their analogs","volume":"17","author":"Scott","year":"2026","journal-title":"RSC Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119365_bib26","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1080\/0886022X.2017.1308257","article-title":"Effect of norcantharidin on the proliferation, apoptosis, and cell cycle of human mesangial cells","volume":"39","author":"Ye","year":"2017","journal-title":"Ren. Fail."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119365_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26041450","article-title":"Exploring the anti-colorectal cancer mechanism of norcantharidin through TRAF5\/NF-kappaB pathway regulation and folate-targeted liposomal delivery","volume":"26","author":"Zhang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119365_bib28","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3892\/ijo.2012.1511","article-title":"Norcantharidin triggers cell death and DNA damage through S-phase arrest and ROS-modulated apoptotic pathways in TSGH 8301 human urinary bladder carcinoma cells","volume":"41","author":"Yu","year":"2012","journal-title":"Int. J. Oncol."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119365_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/antiox13030347","article-title":"Norcantharidin sensitizes colorectal cancer cells to radiotherapy via reactive Oxygen Species-DRP1-Mediated mitochondrial damage","volume":"13","author":"Xu","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejmech.2026.119365_bib30","article-title":"Norcantharidin\/Cu2+ dual-depleting GSH nanocatalyst with pH-responsive for CT\/CDT synergistic cancer therapy","volume":"33","author":"Guo","year":"2025","journal-title":"Mater. Today Bio"},{"issue":"3","key":"10.1016\/j.ejmech.2026.119365_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15030889","article-title":"Codelivery of phytochemicals with conventional anticancer drugs in form of nanocarriers","volume":"15","author":"Kumar","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejmech.2026.119365_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2015.10.019","article-title":"\"Combo\" nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy","volume":"98","author":"Kemp","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119365_bib33","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1021\/acs.chemrev.8b00271","article-title":"Toward multi-targeted platinum and ruthenium Drugs-A new paradigm in cancer drug treatment regimens?","volume":"119","author":"Kenny","year":"2019","journal-title":"Chem Rev"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119365_bib34","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0006-3495(03)74859-0","article-title":"Binding of a fluorescent lipid amphiphile to albumin and its transfer to lipid bilayer membranes","volume":"84","author":"Abreu","year":"2003","journal-title":"Biophys. J."},{"issue":"51","key":"10.1016\/j.ejmech.2026.119365_bib35","doi-asserted-by":"crossref","first-page":"23313","DOI":"10.1002\/anie.202011273","article-title":"Multispecific Platinum(IV) complex deters breast cancer via interposing inflammation and immunosuppression as an inhibitor of COX-2 and PD-L1","volume":"59","author":"Jin","year":"2020","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"12","key":"10.1016\/j.ejmech.2026.119365_bib36","doi-asserted-by":"crossref","first-page":"8227","DOI":"10.1021\/acs.jmedchem.1c02136","article-title":"Pt(IV) prodrugs with non-steroidal anti-inflammatory drugs in the axial position","volume":"65","author":"Spector","year":"2022","journal-title":"J. Med. Chem."},{"issue":"14","key":"10.1016\/j.ejmech.2026.119365_bib37","doi-asserted-by":"crossref","first-page":"7071","DOI":"10.1021\/ac501499y","article-title":"Carbon-dot-based ratiometric fluorescent probe for imaging and biosensing of superoxide anion in live cells","volume":"86","author":"Gao","year":"2014","journal-title":"Anal. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119365_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.171","article-title":"JC-1: alternative excitation wavelengths facilitate mitochondrial membrane potential cytometry","volume":"3","author":"Perelman","year":"2012","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119365_bib39","doi-asserted-by":"crossref","first-page":"8720","DOI":"10.1038\/s41467-024-53047-1","article-title":"Valence-engineered catalysis-selectivity regulation of molybdenum oxide nanozyme for acute kidney injury therapy and post-cure assessment","volume":"15","author":"Li","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.119365_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116454","article-title":"The Active Fraction of polyrhachis vicina Roger (AFPR) activates ERK to cause necroptosis in colorectal cancer","volume":"312","author":"Li","year":"2023","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119365_bib41","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s12011-012-9364-2","article-title":"Pharmacokinetics, tissue distribution, and plasma protein binding study of platinum originating from dicycloplatin, a novel antitumor supramolecule, in rats and dogs by ICP-MS","volume":"148","author":"Zhao","year":"2012","journal-title":"Biol. Trace Elem. Res."},{"issue":"39","key":"10.1016\/j.ejmech.2026.119365_bib42","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1039\/D0AY01328E","article-title":"Fast and reliable ICP-MS quantification of palladium and platinum-based drugs in animal pharmacokinetic and biodistribution studies","volume":"12","author":"Vojtek","year":"2020","journal-title":"Anal. Methods"},{"issue":"9","key":"10.1016\/j.ejmech.2026.119365_bib43","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1177\/0003702816662607","article-title":"Development and validation of an inductively coupled plasma Mass spectrometry (ICP-MS) method for quantitative analysis of platinum in plasma, urine, and tissues","volume":"70","author":"Zhang","year":"2016","journal-title":"Appl. Spectrosc."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119365_bib44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/13880209.2014.912241","article-title":"Pharmacokinetics of cisplatin in the absence or presence of zengmian yiliu granules (a traditional Chinese medicine compound) in rats determined via ICP-MS: an investigation on drug-herb interactions","volume":"53","author":"Zhang","year":"2015","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.ejmech.2026.119365_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2021.213991","article-title":"Recent advances in the synthesis, stability, and activation of platinum(IV) anticancer prodrugs","volume":"442","author":"Xu","year":"2021","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.ejmech.2026.119365_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2023.215578","article-title":"Platinum(IV) and platinum(II) anticancer complexes with biologically active releasable ligands","volume":"501","author":"\u0160tarha","year":"2024","journal-title":"Coord. Chem. Rev."},{"issue":"29","key":"10.1016\/j.ejmech.2026.119365_bib47","doi-asserted-by":"crossref","first-page":"11710","DOI":"10.1039\/C6DT00831C","article-title":"Anticancer activity of a chelating nitrogen mustard bearing tetrachloridoplatinum(iv) complex: better stability yet equipotent to the pt(ii) analogue","volume":"45","author":"Karmakar","year":"2016","journal-title":"Dalton Trans."},{"issue":"32","key":"10.1016\/j.ejmech.2026.119365_bib48","doi-asserted-by":"crossref","first-page":"11934","DOI":"10.1021\/acs.analchem.3c01421","article-title":"Absolute quantification of dynamic cellular uptake of small extracellular vesicles via lanthanide element labeling and ICP-MS","volume":"95","author":"Yang","year":"2023","journal-title":"Anal. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2026.119365_bib49","doi-asserted-by":"crossref","DOI":"10.1093\/mtomcs\/mfac085","article-title":"Single-cell and bulk ICP-MS investigation of accumulation patterns of Pt-based metallodrugs in cisplatin-sensitive and -resistant cell models","volume":"14","author":"Lim","year":"2022","journal-title":"Metallomics"},{"issue":"22","key":"10.1016\/j.ejmech.2026.119365_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20225660","article-title":"Investigations of the kinetics and mechanism of reduction of a carboplatin Pt(IV) prodrug by the major small-molecule reductants in human plasma","volume":"20","author":"Liu","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119365_bib51","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jinorgbio.2011.10.012","article-title":"Pt(IV) complexes as prodrugs for cisplatin","volume":"107","author":"Shi","year":"2012","journal-title":"J. Inorg. Biochem."},{"issue":"29","key":"10.1016\/j.ejmech.2026.119365_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202505567","article-title":"Pyroptosis-Inducing Platinum(IV) prodrugs via GSDME pathway for chemoimmunotherapy and metastasis inhibition in triple-negative breast cancer","volume":"12","author":"Yang","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ejmech.2026.119365_bib53","doi-asserted-by":"crossref","first-page":"5660","DOI":"10.3390\/ijms20225660","article-title":"Investigations of the kinetics and mechanism of reduction of a carboplatin Pt(IV) prodrug by the major small-molecule reductants in human plasma","volume":"20","author":"Liu","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119365_bib54","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1002\/em.22209","article-title":"2,4-Dichlorophenol induces DNA damage through ROS accumulation and GSH depletion in goldfish Carassius auratus","volume":"59","author":"Huang","year":"2018","journal-title":"Environ. Mol. Mutagen."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119365_bib55","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.apsb.2024.06.017","article-title":"Cyclometalated iridium(III) complex based on isoquinoline alkaloid synergistically elicits the ICD response and IDO inhibition via autophagy-dependent ferroptosis","volume":"15","author":"Lu","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2026.119365_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102667","article-title":"Oxidative stress and mitochondrial impairment: key drivers in neurodegenerative disorders","volume":"104","author":"Wen","year":"2025","journal-title":"Ageing Res. Rev."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119365_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202409250","article-title":"Harnessing ROS amplification and GSH depletion using a carrier-free nanodrug to enhance ferroptosis-based cancer therapy","volume":"21","author":"Zhang","year":"2025","journal-title":"Small"},{"issue":"6","key":"10.1016\/j.ejmech.2026.119365_bib58","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1021\/acs.jmedchem.2c00133","article-title":"Copper(II) complexes of halogenated quinoline schiff base derivatives enabled cancer therapy through glutathione-assisted chemodynamic therapy and inhibition of Autophagy flux","volume":"65","author":"Shen","year":"2022","journal-title":"J. Med. Chem."},{"issue":"15","key":"10.1016\/j.ejmech.2026.119365_bib59","doi-asserted-by":"crossref","first-page":"10497","DOI":"10.1021\/acs.jmedchem.3c00603","article-title":"Potent Zinc(II)-Based immunogenic cell death inducer triggered by ROS-Mediated ERS and mitochondrial Ca(2+) overload","volume":"66","author":"Liao","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119365_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103323","article-title":"Tryptanthrin targets GSTP1 to induce senescence and increases the susceptibility to apoptosis by senolytics in liver cancer cells","volume":"76","author":"Zhang","year":"2024","journal-title":"Redox Biol."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119365_bib61","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.31635\/ccschem.020.202000363","article-title":"Pd(II) and Rh(III) complexes with isoquinoline derivatives induced Mitochondria-Mediated apoptotic and autophagic cell death in HepG2 cells","volume":"3","author":"Gul","year":"2021","journal-title":"CCS Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119365_bib62","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1182\/blood-2005-09-3898","article-title":"Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemic cells","volume":"108","author":"Carter","year":"2006","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ejmech.2026.119365_bib63","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/sj.cdd.4400808","article-title":"Pro-caspase-3 overexpression sensitises ovarian cancer cells to proteasome inhibitors","volume":"8","author":"Tenev","year":"2001","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119365_bib64","first-page":"203","article-title":"Inhibition of JAK2\/STAT3 and activation of caspase-9\/3 are involved in KYS05090S-induced apoptosis in ovarian cancer cells","volume":"55","author":"Kim","year":"2019","journal-title":"Int. J. Oncol."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119365_bib65","first-page":"285","article-title":"Zoledronate-induced S phase arrest and apoptosis accompanied by DNA damage and activation of the ATM\/Chk1\/cdc25 pathway in human osteosarcoma cells","volume":"31","author":"Iguchi","year":"2007","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119365_bib66","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1186\/s12951-024-02932-4","article-title":"m6A-modified exosome-derived circHIF1alpha binding to KH domain of IGF2BP3 mediates DNA damage and arrests G1\/S transition phase to resists bacterial infection in bacteremia","volume":"22","author":"Yu","year":"2024","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119365_bib67","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12935-022-02496-z","article-title":"SGLT2 inhibition restrains thyroid cancer growth via G1\/S phase transition arrest and apoptosis mediated by DNA damage response signaling pathways","volume":"22","author":"Wang","year":"2022","journal-title":"Cancer Cell Int."},{"issue":"4","key":"10.1016\/j.ejmech.2026.119365_bib68","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1039\/dt9880001049","article-title":"Acid- and base-catalysed displacement of the carboxylate ligand from [Pt(dien)(RCO2)]+(dien = 1,5-diamino-3-azapentane; R = CH2Cl, CHCl2, or CCl3) in aqueous solution","volume":"17","author":"Canovese","year":"1988","journal-title":"J. Chem. Soc., Dalton Trans."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342600810X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342600810X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:28:45Z","timestamp":1792643325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342600810X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":68,"alternative-id":["S022352342600810X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119365","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Pt(IV) complexes of norcantharidin axial-modulated by carboxylic acid ligand: Synthesis, characterization, in vitro\/in vivo anticancer efficacy and hypoxic activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119365","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119365"}}